table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Biologic Therapeutics Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global Biologic Therapeutics Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Biologic Therapeutics Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Biologic Therapeutics Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Biologic Therapeutics Drugs Industry Impact
Chapter 2 Global Biologic Therapeutics Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biologic Therapeutics Drugs (Volume and Value) by Type
2.1.1 Global Biologic Therapeutics Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global Biologic Therapeutics Drugs (Volume and Value) by Application
2.2.1 Global Biologic Therapeutics Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global Biologic Therapeutics Drugs (Volume and Value) by Regions
2.3.1 Global Biologic Therapeutics Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Biologic Therapeutics Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Biologic Therapeutics Drugs Consumption by Regions (2016-2021)
4.2 North America Biologic Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Biologic Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Biologic Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Biologic Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Biologic Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Biologic Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Biologic Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Biologic Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America Biologic Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Biologic Therapeutics Drugs Market Analysis
5.1 North America Biologic Therapeutics Drugs Consumption and Value Analysis
5.1.1 North America Biologic Therapeutics Drugs Market Under COVID-19
5.2 North America Biologic Therapeutics Drugs Consumption Volume by Types
5.3 North America Biologic Therapeutics Drugs Consumption Structure by Application
5.4 North America Biologic Therapeutics Drugs Consumption by Top Countries
5.4.1 United States Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia Biologic Therapeutics Drugs Market Analysis
6.1 East Asia Biologic Therapeutics Drugs Consumption and Value Analysis
6.1.1 East Asia Biologic Therapeutics Drugs Market Under COVID-19
6.2 East Asia Biologic Therapeutics Drugs Consumption Volume by Types
6.3 East Asia Biologic Therapeutics Drugs Consumption Structure by Application
6.4 East Asia Biologic Therapeutics Drugs Consumption by Top Countries
6.4.1 China Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe Biologic Therapeutics Drugs Market Analysis
7.1 Europe Biologic Therapeutics Drugs Consumption and Value Analysis
7.1.1 Europe Biologic Therapeutics Drugs Market Under COVID-19
7.2 Europe Biologic Therapeutics Drugs Consumption Volume by Types
7.3 Europe Biologic Therapeutics Drugs Consumption Structure by Application
7.4 Europe Biologic Therapeutics Drugs Consumption by Top Countries
7.4.1 Germany Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.2 UK Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.3 France Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia Biologic Therapeutics Drugs Market Analysis
8.1 South Asia Biologic Therapeutics Drugs Consumption and Value Analysis
8.1.1 South Asia Biologic Therapeutics Drugs Market Under COVID-19
8.2 South Asia Biologic Therapeutics Drugs Consumption Volume by Types
8.3 South Asia Biologic Therapeutics Drugs Consumption Structure by Application
8.4 South Asia Biologic Therapeutics Drugs Consumption by Top Countries
8.4.1 India Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Biologic Therapeutics Drugs Market Analysis
9.1 Southeast Asia Biologic Therapeutics Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Biologic Therapeutics Drugs Market Under COVID-19
9.2 Southeast Asia Biologic Therapeutics Drugs Consumption Volume by Types
9.3 Southeast Asia Biologic Therapeutics Drugs Consumption Structure by Application
9.4 Southeast Asia Biologic Therapeutics Drugs Consumption by Top Countries
9.4.1 Indonesia Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East Biologic Therapeutics Drugs Market Analysis
10.1 Middle East Biologic Therapeutics Drugs Consumption and Value Analysis
10.1.1 Middle East Biologic Therapeutics Drugs Market Under COVID-19
10.2 Middle East Biologic Therapeutics Drugs Consumption Volume by Types
10.3 Middle East Biologic Therapeutics Drugs Consumption Structure by Application
10.4 Middle East Biologic Therapeutics Drugs Consumption by Top Countries
10.4.1 Turkey Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa Biologic Therapeutics Drugs Market Analysis
11.1 Africa Biologic Therapeutics Drugs Consumption and Value Analysis
11.1.1 Africa Biologic Therapeutics Drugs Market Under COVID-19
11.2 Africa Biologic Therapeutics Drugs Consumption Volume by Types
11.3 Africa Biologic Therapeutics Drugs Consumption Structure by Application
11.4 Africa Biologic Therapeutics Drugs Consumption by Top Countries
11.4.1 Nigeria Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania Biologic Therapeutics Drugs Market Analysis
12.1 Oceania Biologic Therapeutics Drugs Consumption and Value Analysis
12.2 Oceania Biologic Therapeutics Drugs Consumption Volume by Types
12.3 Oceania Biologic Therapeutics Drugs Consumption Structure by Application
12.4 Oceania Biologic Therapeutics Drugs Consumption by Top Countries
12.4.1 Australia Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America Biologic Therapeutics Drugs Market Analysis
13.1 South America Biologic Therapeutics Drugs Consumption and Value Analysis
13.1.1 South America Biologic Therapeutics Drugs Market Under COVID-19
13.2 South America Biologic Therapeutics Drugs Consumption Volume by Types
13.3 South America Biologic Therapeutics Drugs Consumption Structure by Application
13.4 South America Biologic Therapeutics Drugs Consumption Volume by Major Countries
13.4.1 Brazil Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador Biologic Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Biologic Therapeutics Drugs Business
14.1 Pfizer
14.1.1 Pfizer Company Profile
14.1.2 Pfizer Biologic Therapeutics Drugs Product Specification
14.1.3 Pfizer Biologic Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 AstraZeneca
14.2.1 AstraZeneca Company Profile
14.2.2 AstraZeneca Biologic Therapeutics Drugs Product Specification
14.2.3 AstraZeneca Biologic Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Novartis
14.3.1 Novartis Company Profile
14.3.2 Novartis Biologic Therapeutics Drugs Product Specification
14.3.3 Novartis Biologic Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Merck
14.4.1 Merck Company Profile
14.4.2 Merck Biologic Therapeutics Drugs Product Specification
14.4.3 Merck Biologic Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Smith Medical
14.5.1 Smith Medical Company Profile
14.5.2 Smith Medical Biologic Therapeutics Drugs Product Specification
14.5.3 Smith Medical Biologic Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 GlaxoSmithKline
14.6.1 GlaxoSmithKline Company Profile
14.6.2 GlaxoSmithKline Biologic Therapeutics Drugs Product Specification
14.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Concord Biotech
14.7.1 Concord Biotech Company Profile
14.7.2 Concord Biotech Biologic Therapeutics Drugs Product Specification
14.7.3 Concord Biotech Biologic Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Aurobindo Pharma
14.8.1 Aurobindo Pharma Company Profile
14.8.2 Aurobindo Pharma Biologic Therapeutics Drugs Product Specification
14.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 H. Lundbeck
14.9.1 H. Lundbeck Company Profile
14.9.2 H. Lundbeck Biologic Therapeutics Drugs Product Specification
14.9.3 H. Lundbeck Biologic Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Retractable Technologies
14.10.1 Retractable Technologies Company Profile
14.10.2 Retractable Technologies Biologic Therapeutics Drugs Product Specification
14.10.3 Retractable Technologies Biologic Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Biologic Therapeutics Drugs Market Forecast (2022-2027)
15.1 Global Biologic Therapeutics Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Biologic Therapeutics Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Biologic Therapeutics Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global Biologic Therapeutics Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Biologic Therapeutics Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Biologic Therapeutics Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Biologic Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Biologic Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Biologic Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Biologic Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Biologic Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Biologic Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Biologic Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Biologic Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Biologic Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Biologic Therapeutics Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Biologic Therapeutics Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global Biologic Therapeutics Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global Biologic Therapeutics Drugs Price Forecast by Type (2022-2027)
15.4 Global Biologic Therapeutics Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 Biologic Therapeutics Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
